Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician ...

Clemson basketball's upset win vs. then-No. 2 Duke on Saturday led to its second court storming this season at Littlejohn Coliseum. However, the court storm made Duke coach Jon Scheyer and his ...

When the Auburn men's basketball team visits Vanderbilt tonight, the matchup will pit the nation's top-ranked team against the most-penalized team for field and court storming this school year.

Regeneron Pharmaceuticals announced that the FDA has accepted the resubmission of its Biologics License Application (BLA) for linvoseltamab, an investigational treatment for adult patients with ...

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) Tuesday said that the resubmission of Biologics License Application (BLA) for linvoseltamab for the treatment of multiple myeloma has been ...

As part of its corporate social responsibility, Corporate Sports Network (CSN) has announced plans to renovate the Luzira Prisons basketball court. The initiative is a gesture of appreciation to ...

THE HAGUE, Netherlands — U.S. President Donald Trump’s executive order imposing sanctions on the International Criminal Court (ICC) could jeopardize trials and investigations at the world’s ...

Oswego East’s Mason Lockett, IV, (24) shoots a three against Oswego Allen Cunningham/Sun-Times Share This isn’t the time of the boys basketball season for any team to be hit with an injury ...

Among dozens of court cases challenging President Donald Trump’s policies, one case this week has moved faster than most. In less than 24 hours, the American medical community and dozens of ...

Using CytomX’s Probody and Regeneron’s Veloci-Bi platforms, the collaboration and licensing agreement aims to enable the development of investigational next-generation bispecific immunotherapies.

Last week, the Wildcat basketball players presented the Bourgard family with $5,826.95, all of which was raised through ...